Ken Bate

Kenneth M.
Bate is the founder of JSB-Partners LP, founded in 1999.
Former jobs include Chief Executive Officer at MPM BioImpact LLC from 1997 to 1999; Chief Financial Officer and VP-Sales & Marketing at Biogen MA, Inc. from 1990 to 1996; Chief Financial Officer at Biogen, Inc. from 1990 to 1996; CFO & Head-Commercial Operations at Millennium Pharmaceuticals, Inc. from 2002 to 2005; Director at Coley Pharmaceutical Group, Inc. from 2005 to 2008; President, Chief Executive Officer & Director at NitroMed, Inc. from 2007 to 2009; President, Chief Executive Officer & Director at Archemix Corp.
from 2011 to 2012; Lead Independent Director at Cubist Pharmaceuticals LLC from 2015 to 2016; Independent Non-Executive Director at BioMarin Pharmaceutical, Inc. from 2014 to 2017; Independent Director at Genocea Biosciences, Inc. from 2014 to 2018; Independent Director at Vanda Pharmaceuticals, Inc. from 2015 to 2018; Director at TransMedics, Inc. from 2012 to 2017; Lead Independent Director at AVEO Pharmaceuticals, Inc. from 2007 to 2023; Independent Director at Epizyme, Inc. from 2014 to 2022; Independent Director at Madrigal Pharmaceuticals, Inc. from 2016 to 2025; and Chairman at Astria Therapeutics, Inc. from 2019 to 2026.
Education includes undergraduate studies at Williams College and an MBA from The Wharton School of the University of Pennsylvania.